Recro Pharma Inc reports results for the quarter ended in December - Earnings Summary

Societal CDMO

02/03/2022 05:41

* Recro Pharma Inc  REPH.OQ  reported a quarterly adjusted
loss
of 4 cents​​ per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 7 cents per share.
    * Revenue rose 125% to $22.30 million from a year ago; 
analysts
expected $21.41 million. 
    * Recro Pharma Inc's reported EPS for the quarter was a loss
of 4
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Recro Pharma Inc shares had fallen by 1.8% this quarter.
    * The company reported a quarterly loss of $2.36 million.
    * Wall Street's median 12-month price target for Recro
Pharma Inc
is $5.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 2 at 05:41 a.m.  ​All
figures in US dollars unless otherwise stated